Clinical Trial Update: Study of PEG-Intron for Plexiform Neurofibromas [Phase 2]

View source ↗

Summary

A Phase 2 study of PEG-Intron for Plexiform Neurofibromas has completed enrollment with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plexiform Neurofibroma

Drugs mentioned

• PEG Intron (pegylated interferon alfa-2b)

Snippet

Sponsor: University of Pittsburgh | Conditions: Plexiform Neurofibroma | Phase 2 | Status: COMPLETED | Results posted: 2017-11-06